An Exclusive Interview with Steven Cohen, MD

Share this content:
An Exclusive Interview with Steven Cohen, MD
An Exclusive Interview with Steven Cohen, MD
An Exclusive Interview with Steven Cohen, MD
Chief, GI Medical Oncology
Director, Lung Cancer Section, Division of Hematology/Oncology
Director, Temple University/Fox Chase hematology/oncology fellowship program
Chief Medical Officer, Fox Chase Cancer Center Partners
Fox Chase Cancer Center
Philadelphia, PA

Dr. Steven Cohen, an internationally renowned expert in the treatment of gastrointestinal cancers, offers his comments on the 2012 Annual Meeting of the American Society of Clinical Oncology and the standard of care for gastrointestinal malignancies.

Dr. Cohen discusses one of the posters he presented at ASCO 2012: “U.S. patients receiving resin 90Y microspheres for unresectable colorectal liver metastases: A multicenter study of 506 patients”: : Play
Dr. Cohen discusses the evidence supporting the usefulness of the 90Y radioembolization technique: Play
Dr. Cohen discusses his presentation of the E3204 trial which compared several chemotherapeutic agents in the advanced rectal cancer setting: Play
Dr. Cohen discussed how data he observed and presented at ASCO 2012 will affect his practice: Play

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs